Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Methods Participants Patients aged 1855 with a diagnosis of schizophrenia or schizoaffective disorder were referred to the study by community-based mental healthcare teams in Nottinghamshire, Derbyshire and Lincolnshire, England (for inclusion and exclusion criteria, see SA1 (Supplement)
Can triple agonism outperform incretin therapy
While these effects are generally manageable, they represent more pronounced GI side effects than observed with AOD-9604
3 Proof of Concept for FcRn Targeting in Autoimmunity A key aspect of FcRn as a therapeutic target is its saturable IgG binding site
Bioprocessing of recombinant proteins from Escherichia coli inclusion bodies: Insights from structure-function relationship for novel applications
In recent years, GSH has emerged as a promising therapeutic trigger and biomarker, driving the development of nanotechnology-enabled platforms for controlled drug release, imaging, and theranostics
US$ 28.81
US$ 28.64
US$ 27.36
US$ 21.91
US$ 28.81
